SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QDEL - Quidel more quick diagnosis
QDEL 21.90+10.9%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Wise who wrote (1402)2/19/1998 8:41:00 AM
From: Robert Busse  Read Replies (1) of 1693
 
David, I think you are correct that the royalty payments have hurt Qdel earnings fairly substantially, although I don't think their earning would had doubled without such royalty payments - anyway, your point is well taken that the royalty payments were a substantial detriment to earnings. However, what the Lord taketh away, the Lord also giveth - see my post #1393 re the effect of the NOL carryforward on 4th qtr earnings- this will be much more substantial than the street is anticipating I suspect- presuming Qdel has a decent qtr (and I'm personally expecting their biggest qtr ever) the NOL will not just add a penny or 2 to earnings - it could be as much as a dime or better - some may argue these earnings are "illusory" in the sense that they don't result from a huge increase in revenues and/or sales - however, I think the street tends to focus on earnings surprises and "the bottom line" - I can't help but think a large increase in reported eps will have a very positive and fairly substantial effect on the price of the stock. We'll see. BOB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext